Search Tag: Alan Fuhrman
Tyra Biosciences Announces Planned Chief Financial Officer Transition
2022 02 Nov
- Esther van den Boom to transition to an advisor at year-end 2022- - Alan Fuhrman to be named Chief Financial Officer- Tyra Biosciences, Inc, a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer announced that its Chief Financial Officer, ... Read more